Morgan Stanley’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,107,825
| Closed | -$1.06M | – | 7813 |
|
|
2023
Q2 | $1.06M | Sell |
1,107,825
-38,294
| -3% | -$37.8K | ﹤0.01% | 4793 |
|
|
2023
Q1 | $860K | Sell |
1,146,119
-125,568
| -10% | -$91.6K | ﹤0.01% | 4942 |
|
|
2022
Q4 | $469K | Sell |
1,271,687
-240,902
| -16% | -$102K | ﹤0.01% | 5279 |
|
|
2022
Q3 | $650K | Sell |
1,512,589
-270,504
| -15% | -$266K | ﹤0.01% | 5129 |
|
|
2022
Q2 | $1.39M | Buy |
1,783,093
+125,821
| +8% | +$111K | ﹤0.01% | 4796 |
|
|
2022
Q1 | $2.14M | Sell |
1,657,272
-1,091,027
| -40% | -$1M | ﹤0.01% | 4475 |
|
|
2021
Q4 | $3.49M | Buy |
2,748,299
+1,031,749
| +60% | +$1.84M | ﹤0.01% | 4103 |
|
|
2021
Q3 | $3.74M | Sell |
1,716,550
-793,793
| -32% | -$2.17M | ﹤0.01% | 4019 |
|
|
2021
Q2 | $9.41M | Buy |
2,510,343
+1,289,003
| +106% | +$4.48M | ﹤0.01% | 3061 |
|
|
2021
Q1 | $3.98M | Buy |
1,221,340
+297,174
| +32% | +$1.07M | ﹤0.01% | 3649 |
|
|
2020
Q4 | $3.15M | Buy |
924,166
+533,097
| +136% | +$2.19M | ﹤0.01% | 3760 |
|
|
2020
Q3 | $1.6M | Sell |
391,069
-1,059,523
| -73% | -$4.03M | ﹤0.01% | 3856 |
|
|
2020
Q2 | $4.9M | Sell |
1,450,592
-2,293,927
| -61% | -$6.68M | ﹤0.01% | 2698 |
|
|
2020
Q1 | $8.72M | Buy |
3,744,519
+2,706,554
| +261% | +$7.41M | ﹤0.01% | 1907 |
|
|
2019
Q4 | $3.78M | Buy |
1,037,965
+497,858
| +92% | +$4.02M | ﹤0.01% | 3487 |
|
|
2019
Q3 | $4.48M | Sell |
540,107
-414,893
| -43% | -$3.36M | ﹤0.01% | 2979 |
|
|
2019
Q2 | $8.22M | Buy |
955,000
+632,303
| +196% | +$5.66M | ﹤0.01% | 2365 |
|
|
2019
Q1 | $3.45M | Sell |
322,697
-325,810
| -50% | -$3.49M | ﹤0.01% | 3072 |
|
|
2018
Q4 | $5.67M | Buy |
648,507
+390,424
| +151% | +$4.97M | ﹤0.01% | 2746 |
|
|
2018
Q3 | $4.34M | Sell |
258,083
-52,282
| -17% | -$1.13M | ﹤0.01% | 3334 |
|
|
2018
Q2 | $6.51M | Buy |
310,365
+107,564
| +53% | +$1.99M | ﹤0.01% | 2849 |
|
|
2018
Q1 | $3.26M | Sell |
202,801
-39,327
| -16% | -$779K | ﹤0.01% | 3513 |
|
|
2017
Q4 | $4.59M | Sell |
242,128
-86,376
| -26% | -$1.56M | ﹤0.01% | 3200 |
|
|
2017
Q3 | $4.62M | Buy |
328,504
+155,216
| +90% | +$1.4M | ﹤0.01% | 3037 |
|
|
2017
Q2 | $1.29M | Sell |
173,288
-11,361
| -6% | -$74.2K | ﹤0.01% | 4180 |
|
|
2017
Q1 | $1.2M | Sell |
184,649
-89,656
| -33% | -$501K | ﹤0.01% | 4242 |
|
|
2016
Q4 | $1.22M | Buy |
274,305
+154,843
| +130% | +$649K | ﹤0.01% | 4320 |
|
|
2016
Q3 | $558K | Sell |
119,462
-178,688
| -60% | -$1.06M | ﹤0.01% | 4462 |
|
|
2016
Q2 | $1.96M | Buy |
298,150
+251,232
| +535% | +$1.78M | ﹤0.01% | 3441 |
|
|
2016
Q1 | $298K | Buy |
46,918
+20,428
| +77% | +$105K | ﹤0.01% | 4746 |
|
|
2015
Q4 | $160K | Sell |
26,490
-204,437
| -89% | -$1.17M | ﹤0.01% | 5190 |
|
|
2015
Q3 | $1.38M | Buy |
230,927
+198,016
| +602% | +$1.37M | ﹤0.01% | 3832 |
|
|
2015
Q2 | $225K | Sell |
32,911
-150,249
| -82% | -$954K | ﹤0.01% | 5181 |
|
|
2015
Q1 | $1.11M | Sell |
183,160
-378,901
| -67% | -$2.52M | ﹤0.01% | 4052 |
|
|
2014
Q4 | $3.9M | Buy |
562,061
+417,094
| +288% | +$3.07M | ﹤0.01% | 2963 |
|
|
2014
Q3 | $1.18M | Buy |
144,967
+11,929
| +9% | +$93.3K | ﹤0.01% | 3903 |
|
|
2014
Q2 | $1.08M | Buy |
133,038
+96,287
| +262% | +$731K | ﹤0.01% | 3993 |
|
|
2014
Q1 | $287K | Sell |
36,751
-358,464
| -91% | -$3.03M | ﹤0.01% | 4917 |
|
|
2013
Q4 | $3.5M | Buy |
395,215
+8,907
| +2% | +$79.6K | ﹤0.01% | 2916 |
|
|
2013
Q3 | $3.24M | Sell |
386,308
-268,936
| -41% | -$2.18M | ﹤0.01% | 2836 |
|
|
2013
Q2 | $4.89M | Buy |
+655,244
| New | +$5.03M | ﹤0.01% | 2348 |
|
Morgan Stanley's SPPI Position: Q3 2023 in Review
Morgan Stanley sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 1,107,825 shares — an estimated $1.06M sold.
Morgan Stanley first reported a position in SPPI in Q2 2013 and held it in 41 quarters. The position peaked at $9.41M in Q2 2021. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- Morgan Stanley reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
- Morgan Stanley sold 1,107,825 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $1.06M.
- Morgan Stanley first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 41 quarters.
- Morgan Stanley's Spectrum Pharmaceuticals Inc position peaked at $9.41M in Q2 2021.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.
Based on Morgan Stanley's 13F filing for Q3 2023, filed 15 Nov 2023.